Evidence map›Paper›PMID 42676777›Full record

ArticleNigerian medical journal : journal of the Nigeria Medical Association

Prevalence and Pattern of Chronic Kidney Disease-Associated Pruritus in a Nigerian Teaching Hospital.

Imuetinyan Rashida Edeki, Roli Cynthia Madubuko

Abstract read
In one paragraph

Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Imuetinyan Rashida EdekiRenal unit, Department of Medicine, School of Medicine, College of Medical Sciences, University of Benin, Nigeria.
Roli Cynthia MadubukoDermatology unit, Department of Medicine, School of Medicine, College of Medical Sciences, University of Benin, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic kidney disease (CKD) is a multisystem disease of increasing prevalence and thus of great public health importance. CKD-associated pruritus (CKD-aP) is a common dermatologic manifestation of CKD, and it has been associated with increased occurrences of mood and sleep disorders, increased rates of infection and hospitalization, reduced overall quality of life and increased mortality rates. Methodology: This cross-sectional descriptive study was carried out in a tertiary hospital in Southern Nigeria between June 2024 and August 2024 to determine the prevalence and pattern of CKD-aP in 171 pre-dialysis patients with stages 3-5 CKD. Results: The mean age in this study was 59.9 ± 16.9 years, with females comprising 43.9% of study participants. The prevalence of CKD-aP was 26.9%. The majority (73.9%) had pruritus of moderate severity, and the distribution of pruritus was generalized in 39.1% of those with CKD-aP. There was no significant association observed between gender and aetiology of CKD. (p = 0.364), between gender, aetiology of CKD and pruritus, and between gender, CKD etiology, CKD stage and pruritus severity. CKD stage was a predictor of CKD-aP. (Adjusted odds ratio [AOR]: 2.49; 95% CI: 1.24-5.19; p = 0.011). Conclusion: CKD-aP was relatively common among pre-dialysis CKD, and there was no statistically significant association observed between pruritus, gender, CKD aetiology and CKD stage. It is therefore recommended that CKD-aP should be assessed periodically and managed in all patients with CKD, as this may improve their quality of life and reduce morbidity and mortality.

Indexed as

chronic kidney diseasechronic kidney disease-associated prurituspatternPrevalence

Identifiers

PMID42676777
PMCPMC13527822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.